We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.75B
AUM Growth
+$24.7M
Cap. Flow
-$74.5M
Cap. Flow %
-4.25%
Top 10 Hldgs %
27.66%
Holding
275
New
15
Increased
70
Reduced
162
Closed
18

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$10.8M
2
WNS
WNS Holdings
WNS
+$9.49M
3
FN icon
Fabrinet
FN
+$8.56M
4
ADMA icon
ADMA Biologics
ADMA
+$6.59M
5
YOU icon
Clear Secure
YOU
+$5.91M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 23.6%
3 Industrials 20.27%
4 Communication Services 5.79%
5 Consumer Staples 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWI
176
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.92M 0.11%
152,399
-5,434
-3% -$66.2K
SMID icon
177
Smith-Midland
SMID
$146M
$1.91M 0.11%
40,609
+54
+0.1% +$2.2K
HRMY icon
178
Harmony Biosciences
HRMY
$2.27B
$1.9M 0.11%
56,645
-10,709
-16% -$344K
STAA icon
179
STAAR Surgical
STAA
$1.25B
$1.9M 0.11%
49,565
-3
-0% -$98
ETSY icon
180
Etsy
ETSY
$7.38B
$1.89M 0.11%
27,557
-419
-1% -$30.1K
MLAB icon
181
Mesa Laboratories
MLAB
$569M
$1.79M 0.1%
16,335
+60
+0.4% +$6.04K
VIAV icon
182
Viavi Solutions
VIAV
$9.18B
$1.77M 0.1%
194,573
-17,878
-8% -$175K
CSCO icon
183
Cisco
CSCO
$483B
$1.69M 0.1%
33,882
-447
-1% -$22.3K
ZUMZ icon
184
Zumiez
ZUMZ
$330M
$1.66M 0.09%
109,281
+96
+0.1% +$1.64K
NVDA icon
185
NVIDIA
NVDA
$5.27T
$1.63M 0.09%
18,090
-12,710
-41% -$921K
FLWS icon
186
1-800-Flowers.com
FLWS
$255M
$1.63M 0.09%
150,444
+1,832
+1% +$18.8K
FOUR icon
187
Shift4
FOUR
$3.41B
$1.62M 0.09%
24,475
-5,629
-19% -$423K
HUBG icon
188
HUB Group
HUBG
$2.9B
$1.61M 0.09%
37,246
-15,064
-29% -$659K
CLFD icon
189
Clearfield
CLFD
$391M
$1.57M 0.09%
50,756
-56
-0.1% -$1.6K
NOTV
190
DELISTED
Inotiv
NOTV
$1.56M 0.09%
142,484
+1,735
+1% +$10.4K
OPTN
191
DELISTED
OptiNose
OPTN
$1.45M 0.08%
66,218
-774
-1% -$17.2K
LLY icon
192
Eli Lilly
LLY
$1.1T
$1.43M 0.08%
1,840
-50
-3% -$35.6K
JNJ icon
193
Johnson & Johnson
JNJ
$631B
$1.43M 0.08%
9,030
-81
-0.9% -$12.9K
SCPH
194
DELISTED
scPharmaceuticals
SCPH
$1.41M 0.08%
281,105
+200,101
+247% +$1.12M
ARAY icon
195
Accuray
ARAY
$34.9M
$1.41M 0.08%
570,333
+3,598
+0.6% +$9.63K
YMAB
196
DELISTED
Y-mAbs Therapeutics
YMAB
$1.4M 0.08%
86,146
+633
+0.7% +$8.53K
CODA icon
197
Coda Octopus Group
CODA
$117M
$1.36M 0.08%
235,542
+317
+0.1% +$1.85K
XYL icon
198
Xylem
XYL
$28.3B
$1.35M 0.08%
10,415
-7,754
-43% -$937K
UPWK icon
199
Upwork
UPWK
$1.21B
$1.34M 0.08%
+109,239
New +$1.49M
VICR icon
200
Vicor
VICR
$9.63B
$1.34M 0.08%
34,932
-3,338
-9% -$130K

Similar funds

Rice Hall James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Rice Hall James & Associates held 275 positions worth $1.75B, up 1.4% from $1.73B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rice Hall James & Associates withdrew a net $74.5M in Q1 2024, closing 18 positions and reducing 162 holdings. Its most notable exit was PGT, Inc., an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in ADMA Biologics worth $7.96M.

  • Rice Hall James & Associates's largest Q1 2024 buy was ADMA Biologics: 1,206,499 shares worth $7.96M.
  • Rice Hall James & Associates added most to Alkermes in Q1 2024, an estimated $10.8M increase.
  • Rice Hall James & Associates's biggest Q1 2024 reduction was MASONITE INTERNATIONAL CORP, cutting an estimated $10.2M.
  • Rice Hall James & Associates fully exited PGT, Inc. in Q1 2024, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 28% of its $1.75B portfolio in Q1 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 18 in Q1 2024.
  • Rice Hall James & Associates's portfolio value rose 1.4% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q1 2024, filed 23 Apr 2024.